LIFETECH SCI.DL-00000125 Total Assets
LIFETECH SCI.DL-00000125 total assets. Based on the latest financial reports, LIFETECH SCI.DL-00000125 (81X) holds total assets worth €5.01 Billion EUR (≈ $5.86 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 81X market cap for the company's overall valuation and market capitalisation.
Total Assets of LIFETECH SCI.DL-00000125 (2021–2025)
Total assets of LIFETECH SCI.DL-00000125 from 2021 to 2025. This chart illustrates how LIFETECH SCI.DL-00000125's total assets have evolved over time, based on quarterly financial data. See today's stock price for LIFETECH SCI.DL-00000125 for real-time trading data and today's change.
LIFETECH SCI.DL-00000125 - Asset Composition Analysis
LIFETECH SCI.DL-00000125 Total Assets Breakdown (December 2025)
LIFETECH SCI.DL-00000125 total assets breakdown as of December 2025. LIFETECH SCI.DL-00000125's total assets of €5.01 Billion consist of 46.4% current assets and 53.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 14.4% |
| Accounts Receivable | €161.80 Million | 3.2% |
| Inventory | €444.90 Million | 8.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €779.18 Million | 15.6% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how LIFETECH SCI.DL-00000125's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of LIFETECH SCI.DL-00000125 to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LIFETECH SCI.DL-00000125's current assets represent 46.4% of total assets in 2025, a decrease from 57.7% in 2021.
- Cash Position: Cash and equivalents constituted 14.4% of total assets in 2025, down from 35.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 11.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 15.6% of total assets.
LIFETECH SCI.DL-00000125 Competitors by Total Assets
Key competitors of LIFETECH SCI.DL-00000125 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩253.22 Billion |
|
Paxman AB
ST:PAX
|
Sweden | Skr487.65 Million |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
LIFETECH SCI.DL-00000125 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.57 | 2.86 | 2.68 |
| Quick Ratio | 1.27 | 2.21 | 2.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €845.73 Million | €1.52 Billion | €1.39 Billion |
LIFETECH SCI.DL-00000125 - Advanced Valuation Insights
This section examines the relationship between LIFETECH SCI.DL-00000125's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.02 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | €5.01 Billion |
| Market Capitalization | $848.92 Million USD |
Valuation Analysis
Below Book Valuation: The market values LIFETECH SCI.DL-00000125's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: LIFETECH SCI.DL-00000125's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for LIFETECH SCI.DL-00000125 (2021–2025)
The table below shows the annual total assets of LIFETECH SCI.DL-00000125 from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €5.01 Billion ≈ $5.86 Billion |
+2.29% |
| 2024-12-31 | €4.90 Billion ≈ $5.73 Billion |
+4.34% |
| 2023-12-31 | €4.70 Billion ≈ $5.49 Billion |
+27.27% |
| 2022-12-31 | €3.69 Billion ≈ $4.31 Billion |
+15.91% |
| 2021-12-31 | €3.18 Billion ≈ $3.72 Billion |
-- |
About LIFETECH SCI.DL-00000125
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more